PUMA BIOTECHNOLOGY
Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops innovative products for the treatment of various forms of cancer. The Company focuses on in-licensing drug candidates that are undergoing or have already completed initial clinical testing for the treatment of cancer and then seeks to further develop those drug candidates for commercial use. The Company is initially focused on the development of PB-272 (oral neratinib), a potent irreversible tyrosine kinase inhibitor, for the treatment of patients with HER2 positive metastatic breast cancer.
PUMA BIOTECHNOLOGY
Industry:
Biotechnology Medical Therapeutics
Founded:
2010-01-01
Address:
Los Angeles, California, United States
Country:
United States
Website Url:
http://www.pumabiotechnology.com
Total Employee:
251+
Status:
Active
Contact:
310-443-4150
Email Addresses:
[email protected]
Total Funding:
809.3 M USD
Technology used in webpage:
SPF SSL By Default Google Font API Google Analytics Google Tag Manager Content Delivery Network Google Universal Analytics Font Awesome Domain Not Resolving Global Site Tag
Similar Organizations
Affimed
Affimed Therapeutics is focused on developing recombinant antibody therapeutics for the treatment of cancer and other diseases.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Equity - Puma Biotechnology
Alan H. Auerbach
Alan H. Auerbach investment in Post-IPO Equity - Puma Biotechnology
Armentum Partners
Armentum Partners investment in Post-IPO Debt - Puma Biotechnology
Athyrium Capital Management LP
Athyrium Capital Management LP investment in Post-IPO Debt - Puma Biotechnology
Silicon Valley Bank
Silicon Valley Bank investment in Post-IPO Equity - Puma Biotechnology
Oxford Finance LLC
Oxford Finance LLC investment in Post-IPO Equity - Puma Biotechnology
OrbiMed
OrbiMed investment in Post-IPO Equity - Puma Biotechnology
Sahsen Ventures
Sahsen Ventures investment in Post-IPO Equity - Puma Biotechnology
H&Q Healthcare Investors
H&Q Healthcare Investors investment in Post-IPO Equity - Puma Biotechnology
T. Rowe Price
T. Rowe Price investment in Post-IPO Equity - Puma Biotechnology
Official Site Inspections
http://www.pumabiotechnology.com Semrush global rank: 4.23 M Semrush visits lastest month: 2.78 K
- Host name: 33.187.62.50.host.secureserver.net
- IP address: 50.62.187.33
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
More informations about "Puma Biotechnology"
Leadership Team | Alan H. Auerbach - pumabiotechnology.com
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global …See details»
Puma Biotechnology - Wikipedia
Puma was founded in September 2010 by Alan Auerbach to identify and in-license compounds that were already in clinical development. [2] This was the same business plan Auerbach had …See details»
Puma Biotechnology - Crunchbase Company Profile & Funding
Contact Email [email protected] Phone Number 310-443-4150 Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops …See details»
Product - pumabiotechnology.com
Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in-licensed the global …See details»
Puma Biotechnology, Inc. | LinkedIn
Puma Biotechnology, Inc. Biotechnology Research Los Angeles, CA 10,251 followers At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care.See details»
Puma Biotechnology, Inc. Company Profile | Los Angeles, CA ...
Find company research, competitor information, contact details & financial data for Puma Biotechnology, Inc. of Los Angeles, CA. Get the latest business insights from Dun & Bradstreet.See details»
Puma Biotechnology, Inc. - Investor Relations
Mar 5, 2025 [email protected]. David Schull Russo Partners, LLC. [email protected]. Investor Email Alerts. To opt-in for investor email alerts, …See details»
Puma Biotechnology CEO and Key Executive Team | Craft.co
Puma Biotechnology's Chief Executive Officer, President and Chairman of the Board, Director is Alan H. Auerbach. Other executives include Douglas Hunt, Senior Vice President, Regulatory …See details»
Puma Biotechnology
Feb 25, 2025 Puma Biotechnology, Inc. was founded in August 2010 and is a publicly traded biopharmaceutical company based in Los Angeles, California. The company focuses on …See details»
Working At Puma Biotechnology: Company Overview and Culture
Pumabiotechnology.com. Organization Type. Public. Social Media. Puma Biotechnology, Inc., is a development stage biopharmaceutical company that acquires and develops innovative …See details»
Puma Biotechnology, Inc. - Company Profile & Staff Directory
About Puma Biotechnology, Inc. At Puma Biotechnology, our focus is on bringing innovative therapies to patients to enhance cancer care. We are thankful to be part of the HER2+ breast …See details»
Puma Biotechnology, Inc. - Puma Biotechnology Reports Fourth …
Feb 27, 2025 Puma Biotechnology, Inc. (NASDAQ: PBYI), a biopharmaceutical company, announced financial results for the fourth quarter and year ended December 31, 2024. Unless …See details»
Puma Biotechnology Company Profile - Office Locations ... - Craft
Puma Biotechnology has 4 employees at their 1 location and $230.47 m in annual revenue in FY 2024. See insights on Puma Biotechnology including office locations, competitors, revenue, …See details»
Puma Biotechnology - Overview, News & Similar companies
May 20, 2024 View Puma Biotechnology (www.pumabiotechnology.com) location in California, United States , revenue, industry and description. Find related and similar companies as well …See details»
Puma Biotechnology, Inc. - Drug pipelines, Patents, Clinical
Please dial in at least 10 minutes in advance and inform the operator that you would like to join the “Puma Biotechnology Conference Call.” A live webcast of the conference call and …See details»
Puma Biotechnology to Present Clinical Data on Neratinib at the …
Mar 26, 2025 Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in …See details»
News | February 27, 2025 - Puma Biotechnology Reports Fourth …
Feb 27, 2025 Puma Biotechnology, Inc. is a biopharmaceutical company with a focus on the development and commercialization of innovative products to enhance cancer care. Puma in …See details»
Scientific Resources
The materials available on this website in response to search term queries include Puma-sponsored studies and third-party studies where Puma has provided funding or drug to …See details»
Puma Biotechnology Reports First Quarter Financial Results
15 hours ago Further information about Puma Biotechnology may be found at https://www.pumabiotechnology.com. INDICATIONS. NERLYNX® (neratinib) tablets, for oral …See details»
Puma Biotechnology, Inc. (PBYI) Q1 2025 Earnings Call Transcript
20 minutes ago Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2025 Results Conference Call May 8, 2025 4:30 PM ETCompany ParticipantsMariann Ohanesian - Senior Director...See details»